Discussion about this post

User's avatar
smufty's avatar

I am a recent subscriber and I appreciate your posts on DG. I hope you continue to evaluate this and other companies in similar ways because I find them enlightening and educational. Perhaps Pfizer next?

Expand full comment
Mike's avatar

Too hard for me. There are just too many examples similar to DG where the misery factor (for shareholders) isn't equivalent to the potential payoff.

Expand full comment
2 more comments...

No posts